UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat

Neurobiology of disease, 2002-07, Vol.10 (2), p.119-127

2002

Link zum Volltext

Verfügbarkeit prüfen

Increased striatal dopamine turnover following acute administration of rotenone to mice

Brain research, 2000-12, Vol.885 (2), p.283-288

2000

Link zum Volltext

Verfügbarkeit prüfen

Parkinson’s Disease: Current and Future Challenges

Neurotoxicology (Park Forest South), 2002-10, Vol.23 (4), p.443-450

Langston, J.William

2002

Link zum Volltext

Verfügbarkeit prüfen

Small Molecules Greatly Improve Conversion of Human-Induced Pluripotent Stem Cells to the Neuronal Lineage

Stem Cells International, 2012-01, Vol.2012, p.140427-12

2012

Link zum Volltext

Verfügbarkeit prüfen

An electron microscopic study of MPTP-induced inclusion bodies in an old monkey

Brain research, 1988-05, Vol.448 (1), p.150-157

1988

Link zum Volltext

Verfügbarkeit prüfen

Voluntarily simulated tremor in normal subjects

Neurophysiologie clinique, 2002-04, Vol.32 (2), p.119-126

2002

Link zum Volltext

Verfügbarkeit prüfen

Diethyldithiocarbamate Causes Nigral Cell Loss and Dopamine Depletion with Nontoxic Doses of MPTP

Experimental neurology, 1999-03, Vol.156 (1), p.62-70

1999

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid 3,4-dihydroxyphenylacetic acid level after tolcapone administration as an indicator of nigrostriatal degeneration

Experimental neurology, 2003-09, Vol.183 (1), p.173-179

2003

Link zum Volltext

Verfügbarkeit prüfen

Impaired Glutamate Clearance as a Consequence of Energy Failure Caused by MPP+ in Astrocytic Cultures

Toxicology and applied pharmacology, 1999-08, Vol.158 (3), p.296-302

1999

Link zum Volltext

Verfügbarkeit prüfen

Screening of ferritin light polypeptide 460–461InsA mutation in Parkinson's disease patients in North America

Neuroscience letters, 2002-12, Vol.335 (2), p.144-146

2002

Link zum Volltext

Verfügbarkeit prüfen

Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease

Experimental neurology, 1998-12, Vol.154 (2), p.684-690

1998

Link zum Volltext

Verfügbarkeit prüfen

GDNF Induces a Dystonia-like State in Neonatal Rats and Stimulates Dopamine and Serotonin Synthesis

Neuron (Cambridge, Mass.), 1996-03, Vol.16 (3), p.665-673

1996

Link zum Volltext

Verfügbarkeit prüfen

Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of l-DOPA-treated monkeys

Brain research, 1996-10, Vol.738 (1), p.53-59

1996

Link zum Volltext

Verfügbarkeit prüfen

Diethyldithiocarbamate and disulfiram inhibit MPP + and dopamine uptake by striatal synaptosomes

European journal of pharmacology, 1989-07, Vol.166 (1), p.23-29

1989

Link zum Volltext

Verfügbarkeit prüfen

7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse striatum

Brain research, 1999-08, Vol.839 (1), p.41-48

1999

Link zum Volltext

Verfügbarkeit prüfen

Autoradiographic analysis of dopamine receptor-stimulated [ 35S]GTPγS binding in rat striatum

Brain research, 2000-12, Vol.885 (1), p.133-136

2000

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Neuropathological Features: Session III Summary and Research Needs

Neurotoxicology (Park Forest South), 2001-12, Vol.22 (6), p.833-835

2001

Link zum Volltext

Verfügbarkeit prüfen

1-Methyl-4-phenylpyridinium ion (MPP +): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

Neuroscience letters, 1984-07, Vol.48 (1), p.87-92

1984

Link zum Volltext

Verfügbarkeit prüfen

Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B

European journal of pharmacology, 1990-08, Vol.184 (1), p.119-126

1990

Link zum Volltext

Verfügbarkeit prüfen

Imaging and Therapeutics: The Role of Neuronal Transport in the Regional Specificity of L-DOPA Accumulation in Brain

Molecular imaging and biology, 2002-05, Vol.4 (3), p.208-218

2002

Link zum Volltext

Verfügbarkeit prüfen

Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP

Neuroscience letters, 1987-04, Vol.75 (3), p.323-328

1987

Link zum Volltext

Verfügbarkeit prüfen

V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP + concentrations and neurotoxicity

Life sciences (1973), 1987-02, Vol.40 (8), p.731-740

1987

Link zum Volltext

Verfügbarkeit prüfen

Ultrastructure of eosinophilic inclusion bodies in the amygdala-parahippocampal region of aged squirrel monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin

Neuroscience letters, 1995-01, Vol.184 (1), p.44-47

1995

Link zum Volltext

Verfügbarkeit prüfen

Closer to Parkinson's disease: MPTP and the aging nervous system

Trends in pharmacological sciences (Regular ed.), 1987, Vol.8 (1), p.7-8

Langston, J.William

1987

Link zum Volltext

Verfügbarkeit prüfen

NEUROLOGICAL CONSEQUENCE OF INDUSTRIAL EXPOSURE TO 1-METHYL-4-PHENYL-1, 2, 3, 6-TETRAHYDROPYRIDINE

The Lancet (British edition), 1985-03, Vol.325 (8431), p.747-747

1985

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Animals
(18)
Neurosciences
(18)
Neurosciences & Neurology
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(15)
Male
(14)
Parkinson's Disease
(12)
Mice
(11)
1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
(9)
Dopamine
(9)
Dopamine - Metabolism
(9)
Mice, Inbred C57bl
(9)
Neurology
(9)
Pharmacology & Pharmacy
(8)
Corpus Striatum - Drug Effects
(7)
Corpus Striatum - Metabolism
(7)
Substantia Nigra - Drug Effects
(7)
Humans
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat

Increased striatal dopamine turnover following acute administration of rotenone to mice

Parkinson’s Disease: Current and Future Challenges

Small Molecules Greatly Improve Conversion of Human-Induced Pluripotent Stem Cells to the Neuronal Lineage

An electron microscopic study of MPTP-induced inclusion bodies in an old monkey

Voluntarily simulated tremor in normal subjects

Diethyldithiocarbamate Causes Nigral Cell Loss and Dopamine Depletion with Nontoxic Doses of MPTP

Cerebrospinal fluid 3,4-dihydroxyphenylacetic acid level after tolcapone administration as an indicator of nigrostriatal degeneration

Impaired Glutamate Clearance as a Consequence of Energy Failure Caused by MPP+ in Astrocytic Cultures

Screening of ferritin light polypeptide 460–461InsA mutation in Parkinson's disease patients in North America

Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease

GDNF Induces a Dystonia-like State in Neonatal Rats and Stimulates Dopamine and Serotonin Synthesis

Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of l-DOPA-treated monkeys

Diethyldithiocarbamate and disulfiram inhibit MPP + and dopamine uptake by striatal synaptosomes

7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse striatum

Autoradiographic analysis of dopamine receptor-stimulated [ 35S]GTPγS binding in rat striatum

Clinical and Neuropathological Features: Session III Summary and Research Needs

1-Methyl-4-phenylpyridinium ion (MPP +): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B

Imaging and Therapeutics: The Role of Neuronal Transport in the Regional Specificity of L-DOPA Accumulation in Brain

Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP

V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP + concentrations and neurotoxicity

Ultrastructure of eosinophilic inclusion bodies in the amygdala-parahippocampal region of aged squirrel monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin

Closer to Parkinson's disease: MPTP and the aging nervous system

NEUROLOGICAL CONSEQUENCE OF INDUSTRIAL EXPOSURE TO 1-METHYL-4-PHENYL-1, 2, 3, 6-TETRAHYDROPYRIDINE

Suchergebnisse filtern